HSPA5 and cancer: Utilizing organoids derived from colon cancer patient tumors [63], which offer a more physiologically relevant 3D human cancer model for drug testing, we observed that OLN, in the dosages that suppressed stress induction of GRP78, lowered organoid viability under normal and hypoxic conditions.